These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16602059)

  • 21. Oxidative stress in neurodegenerative diseases.
    Simonian NA; Coyle JT
    Annu Rev Pharmacol Toxicol; 1996; 36():83-106. PubMed ID: 8725383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heme, iron, and the mitochondrial decay of ageing.
    Atamna H
    Ageing Res Rev; 2004 Jul; 3(3):303-18. PubMed ID: 15231238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amyloid-beta: an antioxidant that becomes a pro-oxidant and critically contributes to Alzheimer's disease.
    Kontush A
    Free Radic Biol Med; 2001 Nov; 31(9):1120-31. PubMed ID: 11677045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous activation of Nrf2 and elevation of antioxidant compounds for reducing oxidative stress and chronic inflammation in human Alzheimer's disease.
    Prasad KN
    Mech Ageing Dev; 2016 Jan; 153():41-7. PubMed ID: 26811881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
    Aliev G; Seyidova D; Lamb BT; Obrenovich ME; Siedlak SL; Vinters HV; Friedland RP; LaManna JC; Smith MA; Perry G
    Neurol Res; 2003 Sep; 25(6):665-74. PubMed ID: 14503022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease.
    Smith MA; Nunomura A; Zhu X; Takeda A; Perry G
    Antioxid Redox Signal; 2000; 2(3):413-20. PubMed ID: 11229355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Untangling amyloid-β, tau, and metals in Alzheimer's disease.
    Savelieff MG; Lee S; Liu Y; Lim MH
    ACS Chem Biol; 2013 May; 8(5):856-65. PubMed ID: 23506614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxidative stress in Alzheimer disease and mild cognitive impairment: evidence from human data provided by redox proteomics.
    Swomley AM; Butterfield DA
    Arch Toxicol; 2015 Oct; 89(10):1669-80. PubMed ID: 26126631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo protective effects of ferulic acid ethyl ester against amyloid-beta peptide 1-42-induced oxidative stress.
    Perluigi M; Joshi G; Sultana R; Calabrese V; De Marco C; Coccia R; Cini C; Butterfield DA
    J Neurosci Res; 2006 Aug; 84(2):418-26. PubMed ID: 16634068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Redox regulation of cellular stress response in neurodegenerative disorders.
    Calabrese V; Guagliano E; Sapienza M; Mancuso C; Butterfield DA; Stella AM
    Ital J Biochem; 2006; 55(3-4):263-82. PubMed ID: 17274531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Analysis of the Neurological and Molecular Alterations Underlying the Pathogenesis of Alzheimer's Disease.
    Vidal C; Zhang L
    Cells; 2021 Mar; 10(3):. PubMed ID: 33806317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nitric oxide links mitochondrial fission to Alzheimer's disease.
    Westermann B
    Sci Signal; 2009 May; 2(69):pe29. PubMed ID: 19417214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of oxidative stress in the toxicity induced by amyloid beta-peptide in Alzheimer's disease.
    Miranda S; Opazo C; Larrondo LF; Muñoz FJ; Ruiz F; Leighton F; Inestrosa NC
    Prog Neurobiol; 2000 Dec; 62(6):633-48. PubMed ID: 10880853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxidative stress and Alzheimer disease.
    Christen Y
    Am J Clin Nutr; 2000 Feb; 71(2):621S-629S. PubMed ID: 10681270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. APP and PS-1 mutations induce brain oxidative stress independent of dietary cholesterol: implications for Alzheimer's disease.
    Mohmmad Abdul H; Wenk GL; Gramling M; Hauss-Wegrzyniak B; Butterfield DA
    Neurosci Lett; 2004 Sep; 368(2):148-50. PubMed ID: 15351438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Free radicals in Alzheimer's disease.
    Retz W; Gsell W; Münch G; Rösler M; Riederer P
    J Neural Transm Suppl; 1998; 54():221-36. PubMed ID: 9850931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurotherapeutic effects of novel HO-1 inhibitors in vitro and in a transgenic mouse model of Alzheimer's disease.
    Gupta A; Lacoste B; Pistell PJ; Ingram DK; Hamel E; Alaoui-Jamali MA; Szarek WA; Vlahakis JZ; Jie S; Song W; Schipper HM
    J Neurochem; 2014 Dec; 131(6):778-90. PubMed ID: 25111043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxidative balance in Alzheimer's disease: relationship to APOE, Braak tangle stage, and the concentrations of soluble and insoluble amyloid-β.
    Tayler H; Fraser T; Miners JS; Kehoe PG; Love S
    J Alzheimers Dis; 2010; 22(4):1363-73. PubMed ID: 20930272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidative damage in the olfactory system in Alzheimer's disease.
    Perry G; Castellani RJ; Smith MA; Harris PL; Kubat Z; Ghanbari K; Jones PK; Cordone G; Tabaton M; Wolozin B; Ghanbari H
    Acta Neuropathol; 2003 Dec; 106(6):552-6. PubMed ID: 12955399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.